1.14.15.8	F165I	1.25fold increase in progesterone conversion	693956	
1.14.15.8	additional information	construction of a CYP106A2 knockout strain	-, 711747	
1.14.15.8	D153V/I214F	kcat/Km for conversion of 11-deoxycortisol is 2.64fold higher than wild-type value, progesterone conversion is 93% of wild-type value	693956	
1.14.15.8	D217V	kcat/Km for conversion of 11-deoxycortisol is 2.68fold higher than wild-type value, 1.18fold increase in progesterone conversion	693956	
1.14.15.8	A106T	kcat/Km for conversion of 11-deoxycortisol is 3.17fold higher than wild-type value, 1.43fold increase in progesterone conversion	693956	
1.14.15.8	A106T/R409L	kcat/Km for conversion of 11-deoxycortisol is 3fold higher than wild-type value, 1.43fold increase in progesterone conversion	693956	
1.14.15.8	A106T/Q189K/T399S/R409L	kcat/Km for conversion of 11-deoxycortisol is 4.3fold higher than wild-type value, 1.13fold increase in progesterone conversion	693956	
1.14.15.8	additional information	modelling of CYP106A2 and site-directed mutagenesis of the protein to check the accuracy of the computer-derived model of CYP106A2	696142	
1.14.15.8	T396R	mutant does not produce any hydroxylated product up to an adrenodoxin concentration of 0.1 mM	697323	
1.14.15.8	S72A/V73I	mutant does not show a better stability in the crystallization process than the wild-type protein	696142